Flavonols

Details Flavonols Flavonols

2011-01-04

2011-01-04

Dentz, Bernard (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C549S400000

Reexamination Certificate

active

07863323

ABSTRACT:
A compound of the formula (I):whereinR is selected from the group consisting of H, alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and acyl, each of which may be optionally substituted;R1is an organic moiety that is capable of being converted into a charged group;each X and Y is independently selected from the group consisting of H, halogen, —CN, —NO2, —CF3, —OCF3, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, heteroalkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl, arylalkenyl, cycloalkylheteroalkyl, arylheteroalkyl, heterocycloalkylheteroalkyl, heteroarylheteroalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, alkoxyaryl, alkenyloxy, alkynyloxy, cycloalkyloxy, heterocycloalkyloxy, aryloxy, heteroaryloxy, arylalkyloxy, phenoxy, benzyloxy, amino, alkylamino, aminoalkyl, acylamino, arylamino, sulfonylamino, sulfinylamino, —COOH, —COR2, —COOR2, —CONHR2, —NHCOR2, —NHCOOR2, —NHCONHR2, C(═NOH)R2, alkoxycarbonyl, alkylaminocarbonyl, sulfonyl, alkylsulfonyl, alkylsulfinyl, arylsulfonyl, arylsulfinyl, aminosulfonyl, SR2and acyl, each of which may be optionally substituted;each R2is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, haloalkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl, and acyl, each of which may be optionally substituted;m is an integer selected from the group consisting of 0, 1, 2, 3, 4 and 5;p is an integer selected from 0, 1, 2 and 3;or a pharmaceutically acceptable salt or prodrug thereof.

REFERENCES:
patent: 6329189 (2001-12-01), Kinoshita et al.
patent: 2005/0245487 (2005-11-01), Murphy et al.
Picq et al, J. Med. Chem. , vol. 25, pp. 1192-1198 (1982).
Valenti et al, Anti-Cancer Drug Desigh vol. 11, p. 243-252 (1996).
Adlam, et al., “Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury” inThe FASEB Journal, Research Communication, (Jul. 2005), vol. 19, pp. 1088-1095.
Van Acker, et al., “Synthesis of Novel 3.7-Substituted-2-(3′,4′-dihydroxyphenyl) flavones with Improved Antioxidant Activity”J. Med. Chem, (2000), vol. 43, pp. 3752-3760.
Woodman, et al., “Vascular and Anti-Oxidant Actions of Flavonols and Flavones”Clinical and Experimental Pharmacology and Physiology, (2004), vol. 31, pp. 786-790.
Calias, et al., “Synthesis of inositol 2-phosphate-quercetin conjugates”Carbohydrate Research, (1996), vol. 292, pp. 83-90.

Affiliated with

Also associated with

Rating

Flavonols does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Flavonols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flavonols will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2697351